Decrease RTR, IR, and CR Due to Dissolution Deficiencies (21of28) GDF – Apr. 3-4, 2019
25:40
Impurity Case Studies: Pharmacology/Toxicology (22of28) Generic Drugs Forum – Apr. 3-4, 2019
21:56
Filing and Refuse to Receive (RTR) (16of28) Generic Drugs Forum – Apr. 3-4, 2019
16:57
In Vitro Drug Release Testing for LA Drug Products QC (16of35) Complex Generics - Sep. 25-26, 2019
23:35
Division of Filing Review: Helpful Tips for Submission of an ANDA or Controlled Correspondence
21:57
Biopharmaceutics Risk Assessment to Guide Dissolution Method Development for Solid Oral Dosage Forms
15:23
Dissolution Method Development for Generic Drugs (24/28) Generic Drugs Forum 2017
27:10
Overview of Post-approval Chemistry, Manufacture, and Controls (CMC) Changes to an NDA - REdI 2020
28:12